Literature DB >> 20523104

Isolation and characterization of fetus human retinal microvascular endothelial cells.

Zhang Xiaozhuang1, Luo Xianqiong, Jiang Jingbo, Huang Shuiqing, Yan Jie, Chen Yunbin.   

Abstract

PURPOSE: To isolate and characterize primary fetus retinal microvascular endothelial cells (RMECs) in order to facilitate the study of their properties in vitro.
METHODS: Human RMECs were isolated from abortive fetuses whose gestational ages were between 20 and 28 weeks by mechanical morcel and trypsin-collagenase digestion, plated on fibronectin-coated wells and purified gradually in high-selective condition. The RMECs were characterized for expression and localization of endothelial cell markers by indirect immunocytochemical staining of von Willebrand factor (vWF) and CD34, the distribution of cell markers was observed by confocal immunofluorescence microscope. The ability of these cells to form capillary-like networks was assessed subsequently. Cobalt dichloride (CoCl2) was used to simulate hypoxia in the culture condition and Western blot was used to detect the alternation of VEGF protein level under normoxia and hypoxia.
RESULTS: Isolation of fetus RMECs has been very difficult and primary culture of these special premature RMECs has not been previously reported due to many reasons. Here we established a simple and convenient method for the primary culture of fetus human RMECs. Our results show that delicate RMECs could be obtained readily and grow very fast, and the purity of RMECs was up to 95% demonstrated by specific staining for vWF in the cytoplasm. Our research also indicates that nearly 100% of cells could express CD34. The cells were successfully passaged and maintained in culture for 5-7 passages without a significant loss in expression of endothelia cell markers. The fetus RMECs formed capillary-like networks on the Matrigel well. Expression of VEGF protein increased significantly under hypoxia.
CONCLUSIONS: Pure fetus RMECs could be obtained rapidly and easily by our method.Fetus RMECs have some specific properties. Hypoxia could induce expression of VEGF. Cell properties related with age of the donors should be considered while studying in vitro, especially in some age-specific diseases such as retinopathy of prematurity and diabetic retinopathy. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523104     DOI: 10.1159/000315364

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  5 in total

1.  Characterization of human fetal brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB with syngenic co-cultures.

Authors:  Allison M Andrews; Evan M Lutton; Lee A Cannella; Nancy Reichenbach; Roshanak Razmpour; Matthew J Seasock; Steven J Kaspin; Steven F Merkel; Dianne Langford; Yuri Persidsky; Servio H Ramirez
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-23       Impact factor: 6.200

Review 2.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

3.  Influence of subretinal fluid in advanced stage retinopathy of prematurity on proangiogenic response and cell proliferation.

Authors:  Jie Ma; Manisha Mehta; Godfrey Lam; Desireé Cyr; Tat Fong Ng; Tatsuo Hirose; Khaled A Tawansy; Andrew W Taylor; Kameran Lashkari
Journal:  Mol Vis       Date:  2014-06-21       Impact factor: 2.367

4.  The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy.

Authors:  Xiaohua Li; Xiaohui Liu; Haoyi Guo; Zhaoxia Zhao; Yun Sui Li; Guoming Chen
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

5.  Identification of Iron Homeostasis Genes Dysregulation Potentially Involved in Retinopathy of Prematurity Pathogenicity by Microarray Analysis.

Authors:  Xian-Qiong Luo; Chun-Yi Zhang; Jia-Wen Zhang; Jing-Bo Jiang; Ai-Hua Yin; Li Guo; Chuan Nie; Xu-Zai Lu; Hua Deng; Liang Zhang
Journal:  J Ophthalmol       Date:  2015-10-18       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.